Established on February 1, 2011 in the Bordeaux area, Bordeaux Clinical Research Network (BCRN) is a service platform dedicated to clinical trials in the healthcare industry. It aims to fulfill the increasing requirements of CROs and healthcare professionals to boost and speed up patient inclusion in phase I to IV clinical trials, while still ensuring compliance with all applicable quality standards.
BCRN offers international pharmaceutical companies and CROs a clinical trial platform in France, with easy access to a significant number of patients in a wide range of therapeutic fields.
For the first time in Europe industries, hospitals and universities have joined forces to achieve the following goals:
- Obtain higher patient inclusion rates in high-potential clinical trials
- Provide industries and hospitals with a unique gateway and enable them to connect, to effectively streamline procedures and to reduce lead time on trials
- Strengthen the relationship between hospitals and primary-care providers to optimize patients enrollment
BCRN is a Site Management Organization (SMO) offering a wide range of services including:
1. Assistance in setting up clinical trials
- Analyzing protocols and identifying investigators
- Defining logistical requirements and offering adequate services
- Elaborating budgets and financial proposals
- Providing a single contract for all parties involved
2. Reinforcement of investigation/site management capabilities
- Allocating and managing medical and paramedical staff
- Increasing the involvement of primary-care providers in the enrollment, inclusion and monitoring of patients
- Assuring administrative and logistical support to the primary-care providers’ network
3. Support to innovative projects
- Analyzing the various requirements
- Drafting agreements
- Identifying means of investigation
- Assisting with regulatory procedures
- Implementing and supervising projects
BCRN combines the assets and skills of its co-founders :
- Bordeaux University Hospital
- The Bergonié Institute (Regional Cancer Center)
- Bordeaux Segalen University
- SARI (Société d’Accompagnement à la Recherche Industrielle), a French company dedicated to the support of industrial research. This company was set up by the Bordeaux Chamber of Commerce and Industry and brings together twelve local SMEs specialized in pharmaceuticals, medical devices and nutrition.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.